Light heavyweight Michal Oleksiejczuk has accepted a one-year suspension from the U.S. Anti-Doping Agency following a failed test at UFC 219, the UFC anti-doping partner today announced.
Oleksiejczuk’s (13-1 MMA, 0-0 UFC) punishment mirrors one handed down by the Nevada State Athletic Commission, which overturned his decision win over Khalil Rountree (6-2 MMA, 2-2 UFC) this past December and fined him $3,600 in addition to attorney’s fees.
Oleksiejczuk came up positive for the estrogen blocker clomiphene following an in-competition drug test. Clomiphene can be used in conjunction with performance-enhancers and is banned year round. It was the banned substance found in previous anti-doping offenses by ex-UFC champs Jon Jones and Brock Lesnar.
As a condition of his USADA suspension, Oleksiejczuk must submit to random drug testing. He must also provide a clean drug test to the NSAC at intervals of 30, 15, and three days prior to being licensed, and he must pay his fines.
The suspensions brought a swift halt to Oleksiejczuk’s nine-fight winning streak in international competition. He was a betting underdog heading into his Dec. 30 fight with Rountree, who’d won his past two fights prior to UFC 219.
- Daily Debate results: Is Kelvin Gastelum the best option for UFC champ Robert Whittaker?
- Why the 'Showtime kick' was a mixed blessing for ex-UFC champ Anthony Pettis
- Watch MMAjunkie Radio here (1 p.m. ET) with Jorge Masvidal and Keri Melendez
Source: USA Today – MMA Junkie
Read the full article here: Michal Oleksiejczuk gets one-year suspension (clomiphene) due to failed UFC 219 drug test